Paradoxically, higher FGF21 level was observed in obesity-related diseases including nonalcoholic fatty liver disease [3], coronary heart disease [4], type 2 diabetes mellitus (T2DM) [5] and metabolic syndrome [6], which may be resulted from FGF21 resistance. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.